Dosing Finishes in Trial of NurOwn Cell Therapy for Progressive MS
Patient dosing has finished in a Phase 2 clinical trial testingĀ NurOwn, BrainStorm Cell Therapeuticsā investigational cell-based therapy for people with progressive multiple sclerosis…